New MetabolAid offers breakthrough in natural treatment of metabolic syndrome

Monteloeder has launched a ground-breaking botanical ingredient that tackles metabolic syndrome – a dangerous condition in which high blood pressure, high cholesterol and obesity combine to increase greatly the risk of someone developing type 2 diabetes or cardiovascular disease.

Four years in development, MetabolAid is a combination of two plants – a hibiscus variety (Hibiscus sabdariffa) and lemon verbena (Aloysia triphylla). Together these well-known and safe herbal extracts provide a synergistic effect that addresses the key causes of metabolic syndrome.

Pre-clinical tests involving mice fed on a high-fat diet have shown that the active compounds in MetabolAid influence key metabolic enzymes that regulate cholesterol levels, glucose accumulation and lipolysis (fat breakdown)– all of which are factors that can trigger metabolic syndrome. Specifically, the studies showed an activation of PPAR-alpha, a receptor that promotes the breakdown of fat and lowers cholesterol, and AMPK, an enzyme that promotes energy burn. Researchers also observed in the mice an inhibition of FASN, an enzyme that promotes the creation of fat.

A pilot clinical study involving fifty overweight and moderately obese volunteers is currently underway at the University Miguel Hernández de Elche in Spain to demonstrate the benefits of MetabolAid in humans, and the preliminary outcomes are very promising. The subjects have been divided into two groups, with one receiving a formula containing 500mg of MetabolAid and the other a placebo.

In total seventeen participants have completed the first month of analysis, and the results show a greater reduction in blood pressure in the MetabolAid group than in the placebo group, higher levels of HDL (good) cholesterol in the MetabolAid group, compared with a small decrease in the placebo group, a reduction in LDL (bad) cholesterol in the MetabolAid group, compared with an increase in the placebo group and a lower level of the transaminases (enzymes) associated with liver damage in the MetabolAid group than in the placebo group.

Fernando Cartagena, Director of Monteloeder, says, “Metabolic syndrome is a global problem. It is estimated to affect 40% of Americans and 30% of Europeans aged 50 years and over, and a solution to this epidemic is required urgently. However, in spite of this, there’s a surprising lack of approved and effective natural products to address metabolic syndrome. But the launch of MetabolAid means there is now a natural, safe and proven ingredient with the potential to help alleviate the burden it places on healthcare systems and enable people everywhere to lead healthier and happier lives.”


Signs of economic recovery at Hispack & BTA

Hispack & BTA closed its third joint edition at the Fira de Barcelona Gran Via exhibition centre, confirming a change of trend in the industry and the economy that indicates a recovery.

At the close of this show, with the final figures yet to come in, both shows are set to reach close to 38,000 trade visitors, 8% more than the expected total. Exhibitors have highlighted the quality of visitors who, unlike during the economic downturn, have come with definite plans for investment, and the increase in number of foreign visitors, from 112 countries, 10.6% of the total.

The packaging and food technology sectors have witnessed the recovery of the national market at Hispack & BTA, with an excellent response from visitors from all the Autonomous Communities who have come to the show seeking mainly innovation and solutions to improve their firms’ competitiveness and to launch new products, as well as to find out about the latest trends.

The international component has become more prominent at this edition. It is estimated that some 3800 foreign visitors have been to Hispack & BTA, where some 700 meetings took place between exhibitors and buyers from 29 countries invited by the organisation. The aim is to boost exports of both packaging and food technology. Along with European countries such as Portugal, France, Italy, Germany and the UK, there was a notable increase in the number of industry professionals at this edition, from Morocco, Mexico, Tunisia and Colombia.

The number of exhibiting companies of both Hispack and BTA have increased. The two trade fairs together drew 1250 companies, 6% more than in 2012, demonstrating the different stages of food products, from ingredients to equipment and technologies for the manufacturing process, including packages and packaging, logistics and arrival at the point of sale. Likewise, sectors such as pharmaceuticals, chemicals, drugs, perfumery and cosmetics, amongst others, found tailored processing and packaging solutions at Hispack.

The activities programmed for the shows proved very popular. Hispack featured over 200 presentations in its four themed areas – Trendpack, Premiumpack, Retail Area and Pack & Logistic Corner – while at BTA there were close to forty sessions on the latest trends in food tech innovation, presentations of new products and round table sessions. The Líderpack Bta. Innova and Bta. Emprende awards ceremonies also took place.

The next joint edition of the International Packaging Exhibition, Hispack, and Alimentaria FoodTech, the new name of BTA, will be in 2018.


RedArc supports ground breaking Group Income Protection

Specialist nurse service provider RedArc is to support Havensrock’s newly launched Group Income Protection solution, the first scheme to provide financial and emotional support to employees who become too ill to work as well as aiming to improve the overall health of all staff.

Through its qualified Nurse Advisers, RedArc will offer valuable support and advice to any employee or family member who falls ‘long term’ sick. The service is tailored specifically to each individual and their illness, whether it is a serious physical or mental condition, disability, trauma, stress or bereavement. This will include extending and enhancing what is available from mainstream services such as the NHS and Social Services.

For the first time with Havensrock, income protection is wellness-enabled. Like more traditional policies, it still provides financial help for members who are too ill to work, but it is also uniquely based on employee wellness, education and engagement to proactively improve workplace health and reduce sickness absence.

Each employee receives a Fitbug Orb, a personal, easy-to-use, wearable movement and sleep tracker to help monitor and meet their individual health and wellbeing goals. Also they will have access to an annual MOT via a mobile interactive health kiosk to record their general health indicators including weight, height, body mass index, body fat index, blood pressure, resting heart rate, hydration and life balance.

RedArc’s managing director Christine Husbands said, “To be part of a new and ground breaking solution for employee protection is very exciting and we look forward to playing our part as we have always prided ourselves on being there for people who really benefit from our services.”